AnaptysBio, Inc. (ANAB)
59.79
+1.05
(+1.79%)
USD |
NASDAQ |
May 19, 16:00
59.79
0.00 (0.00%)
After-Hours: 18:48
AnaptysBio Profit Margin (Quarterly) : -206.9% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -93.91% |
| TG Therapeutics, Inc. | 9.65% |
| ADMA Biologics, Inc. | 39.59% |
| Mirum Pharmaceuticals, Inc. | -494.2% |
| Rocket Pharmaceuticals, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.36K% |
| Return on Assets | -7.42% |
| Return on Invested Capital | -8.28% |
| Gross Profit Margin (Quarterly) | 97.61% |
| Operating Margin (Quarterly) | -135.5% |
| Return on Net Operating Assets | -54.22% |